No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs3021528 |
chr12:63545986-63545987 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs558340404 |
chr12:63546069-63546070 |
Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs75397752 |
chr12:63546118-63546119 |
Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs552843665 |
chr12:63546126-63546127 |
Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs538651356 |
chr12:63546272-63546273 |
Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs534646833 |
chr12:63546283-63546284 |
Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs553726754 |
chr12:63546418-63546419 |
Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs3021527 |
chr12:63546527-63546528 |
Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs542679309 |
chr12:63546563-63546564 |
Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs145801755 |
chr12:63546570-63546571 |
Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs74097656 |
chr12:63546618-63546619 |
Weak transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs533542253 |
chr12:63546634-63546635 |
Weak transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs375701155 |
chr12:63546642-63546643 |
Weak transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs370003100 |
chr12:63546646-63546647 |
Weak transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs2738253 |
chr12:63546709-63546710 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs374384141 |
chr12:63546733-63546734 |
Weak transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs146924260 |
chr12:63546744-63546745 |
Weak transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs572107783 |
chr12:63546745-63546746 |
Weak transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs185713771 |
chr12:63546752-63546753 |
Weak transcription Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs188802530 |
chr12:63546926-63546927 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs541782491 |
chr12:63546945-63546946 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs561437620 |
chr12:63547001-63547002 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs540815301 |
chr12:63547039-63547040 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs553811941 |
chr12:63547053-63547054 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs147593272 |
chr12:63547070-63547071 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs72437702 |
chr12:63547084-63547085 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs4026925 |
chr12:63547092-63547093 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs375871329 |
chr12:63547096-63547097 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs373455174 |
chr12:63547097-63547098 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs192185649 |
chr12:63547100-63547101 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs140940225 |
chr12:63547104-63547105 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs145866023 |
chr12:63547110-63547111 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs3087488 |
chr12:63547114-63547115 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs184430878 |
chr12:63547118-63547119 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs72112718 |
chr12:63547124-63547125 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs141249341 |
chr12:63547126-63547127 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs59810281 |
chr12:63547134-63547135 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs113697298 |
chr12:63547147-63547148 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs374220840 |
chr12:63547153-63547154 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs532627371 |
chr12:63547154-63547155 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs570711884 |
chr12:63547190-63547191 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs112436328 |
chr12:63547210-63547211 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs10877969 |
chr12:63547239-63547240 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs188481744 |
chr12:63547240-63547241 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs559537796 |
chr12:63547282-63547283 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs534525824 |
chr12:63547302-63547303 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs3759292 |
chr12:63547313-63547314 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs181596816 |
chr12:63547381-63547382 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs185773185 |
chr12:63547384-63547385 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs372462807 |
chr12:63547448-63547449 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|